Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

INTRODUCTION: Randomized clinical trials (RCTs) and real-world data (RWD) in patients with atrial fibrillation have shown that—compared to vitamin K antagonists (VKAs)—non-VKA oral anticoagulants (NOACs) are at least as effective in the prevention of ischaemic stroke, while decreasing the risk of bl...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Lisa A., Groeneveld, Jessie, Stevanovic, Jelena, Rila, Harrie, Tieleman, Robert G., Huisman, Menno V., Postma, Maarten J., van Hulst, Marinus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748426/
https://www.ncbi.nlm.nih.gov/pubmed/31527894
http://dx.doi.org/10.1371/journal.pone.0222658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748426/
https://www.ncbi.nlm.nih.gov/pubmed/31527894
http://dx.doi.org/10.1371/journal.pone.0222658

Ejemplares similares